Pirifibrate

This classification denotes an anti-lipidemic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E82B3Z65BN. European Medicines Agency schedules Pirifibrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09913MIG. Pirifibrate generally arises in the molecular formula C17H18CLNO4. The term PIRIFIBRATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, no. 10 1979, list 19.) PIRIFIBRATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pirifibrate under HS 29333999 and SITC 51574. As of Q4 2014, PIRIFIBRATE remains the US FDA Preferred Term for this commodity. Pirifibrate bears US NLM identifiers UMLS ID C0071136 and NCI Concept Code C66421. SMILES: Clc1ccc(OC(C)(C)C(=O)OCc2nc(ccc2)CO)cc1.